Phyla: Funding, Investors & Team (Sep 2026)
Phyla is creating elective treatments for anti-infection agents. The focal point of most microbiome endeavors is to find valuable microorganisms to add to the microbiome, to fix sickness or keep up with wellbeing. Anyway others miss the mark on subtractive capability that can eliminate hurtful or illness causing microorganisms, that would permit the microbiome to rebalance and accomplish a stable sound state. Involving bacteriophages as an establishment, they are fostering a strong stage that permits us to specifically 'deduct' terrible microorganisms without hurting the great strains present locally. It's a piece like utilizing an expert marksman rather than an explosive to take out a trouble maker in a horde of individuals.
Phyla has raised $2.0M across 2 funding rounds on record, the most recent a Series A announced in Dec 2023.
Phyla Company Profile and Key Stats
Latest funding round on record: Dec 2023.
Phyla Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Phyla raised $2.0M in a Seed announced in Jul 2022.
1.4 years later, a Series A was announced in Dec 2023 with no disclosed amount.
Phyla Founders and Leadership Team
Contact details for the Phyla team: 1 of 1 has an email address on file.
Start 14-day free trial →Phyla Funding Compared to Other Biotechnology Startups
Funded Startups Like Phyla in Biotechnology and San Francisco
Companies Similar to Phyla
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Phyla Funding FAQs
What does Phyla do?
Phyla is creating elective treatments for anti-infection agents. The focal point of most microbiome endeavors is to find valuable microorganisms to add to the microbiome, to fix sickness or keep up with wellbeing. Anyway others miss the mark on subtractive capability that can eliminate hurtful or illness causing microorganisms, that would permit the microbiome to rebalance and accomplish a stable sound state. Involving bacteriophages as an establishment, they are fostering a strong stage that permits us to specifically 'deduct' terrible microorganisms without hurting the great strains present locally. It's a piece like utilizing an expert marksman rather than an explosive to take out a trouble maker in a horde of individuals.
How much funding has Phyla raised?
Phyla has raised $2.0M across 2 rounds on record.
When did Phyla last raise funding?
Phyla's most recent funding round on record was announced in Dec 2023. The amount was not disclosed.
Who founded Phyla?
FundedIQ lists Yug Varma (Founder) at Phyla.
Where is Phyla headquartered?
Phyla is based in San Francisco, California, United States.
How many employees does Phyla have?
Phyla is in the 1-10 employee band.
About FundedIQ's Phyla Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Phyla is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.